Lower prevalence of Blastocystis sp. infections in HIV positive compared to HIV negative adults in Ghana.
Adult
Animals
Blastocystis
/ classification
Blastocystis Infections
/ complications
Cohort Studies
Coinfection
/ epidemiology
Female
Ghana
/ epidemiology
HIV Infections
/ complications
HIV Seronegativity
/ immunology
HIV Seropositivity
/ complications
Humans
Male
Middle Aged
Prevalence
Prospective Studies
Risk Factors
Young Adult
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
16
05
2019
accepted:
18
08
2019
entrez:
4
9
2019
pubmed:
4
9
2019
medline:
17
3
2020
Statut:
epublish
Résumé
Sub-Saharan Africa is endemic for intestinal parasites and distinguished for the largest burden of HIV cases. Blastocystis sp. is one of the most common protists infecting humans but its role in human disease is still controversial. Aim of this study was to investigate the prevalence of Blastocystis sp. in HIV positive and negative adults in Ghana and its association with immune status and other risk factors. 122 HIV positive outpatients and 70 HIV negative blood donors from the Komfo Anokye Teaching Hospital in Kumasi, Ghana, were included in the present study. Demographic, clinical and laboratory data were collected and HIV positive patients distinguished for CD4+ T cell count <200 cells/μl (n = 54) and >200 cells/μl (n = 68). A Blastocystis's phylogenetic analysis was performed to determine sample subtype (ST). The prevalence of Blastocystis sp. in adult HIV positive individuals was lower than in HIV negative persons (6.6% vs. 20.0%, p = 0.008) and Blastocystis sp. ST1 was the most prevalent strain. Within HIV positive participants, the prevalence of Blastocystis sp. was lower in those individuals with CD4+ T cell count <200 cells/μl than in patients with higher CD4+ T cell count (1.9% vs. 10.3%, p = 0.076). Multiple regression analysis revealed that Blastocystis sp. was inversely associated with an obese Body Mass Index (BMI) in HIV negative persons (p = 0.040). Presence of Blastocystis sp. was correlated with higher CD4+ T cell count in HIV positive participants (p = 0.049). It is largely reported that people living with HIV (PLHIV) in Africa are affected from parasite infections and that co-infections may adversely impact on their immune status, accelerating progress to AIDS and worsening gastrointestinal manifestations. Differently, in this study Blastocystis sp. was associated with a better immune status jointly with a healthy body weight while it seems to be reduced with the progression of HIV infection. This data agree with recent suggestions that Blastocystis sp. can represent a component of the healthy gut microbiota.
Sections du résumé
BACKGROUND
Sub-Saharan Africa is endemic for intestinal parasites and distinguished for the largest burden of HIV cases. Blastocystis sp. is one of the most common protists infecting humans but its role in human disease is still controversial. Aim of this study was to investigate the prevalence of Blastocystis sp. in HIV positive and negative adults in Ghana and its association with immune status and other risk factors.
METHODS
122 HIV positive outpatients and 70 HIV negative blood donors from the Komfo Anokye Teaching Hospital in Kumasi, Ghana, were included in the present study. Demographic, clinical and laboratory data were collected and HIV positive patients distinguished for CD4+ T cell count <200 cells/μl (n = 54) and >200 cells/μl (n = 68). A Blastocystis's phylogenetic analysis was performed to determine sample subtype (ST).
RESULTS
The prevalence of Blastocystis sp. in adult HIV positive individuals was lower than in HIV negative persons (6.6% vs. 20.0%, p = 0.008) and Blastocystis sp. ST1 was the most prevalent strain. Within HIV positive participants, the prevalence of Blastocystis sp. was lower in those individuals with CD4+ T cell count <200 cells/μl than in patients with higher CD4+ T cell count (1.9% vs. 10.3%, p = 0.076). Multiple regression analysis revealed that Blastocystis sp. was inversely associated with an obese Body Mass Index (BMI) in HIV negative persons (p = 0.040). Presence of Blastocystis sp. was correlated with higher CD4+ T cell count in HIV positive participants (p = 0.049).
CONCLUSION
It is largely reported that people living with HIV (PLHIV) in Africa are affected from parasite infections and that co-infections may adversely impact on their immune status, accelerating progress to AIDS and worsening gastrointestinal manifestations. Differently, in this study Blastocystis sp. was associated with a better immune status jointly with a healthy body weight while it seems to be reduced with the progression of HIV infection. This data agree with recent suggestions that Blastocystis sp. can represent a component of the healthy gut microbiota.
Identifiants
pubmed: 31479472
doi: 10.1371/journal.pone.0221968
pii: PONE-D-19-13925
pmc: PMC6719849
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0221968Subventions
Organisme : Medical Research Council
ID : MR/J01477X/1
Pays : United Kingdom
Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
ISME J. 2017 Dec;11(12):2848-2863
pubmed: 28837129
Trans R Soc Trop Med Hyg. 2013 Aug;107(8):502-10
pubmed: 23783759
Parasitol Res. 2004 Jan;92(1):22-9
pubmed: 14598169
Infect Dis Poverty. 2013 Aug 23;2(1):18
pubmed: 23971713
Parasit Vectors. 2018 Jan 29;11(1):67
pubmed: 29378626
Parasitol Res. 2009 Aug;105(2):413-21
pubmed: 19290540
J Infect Dev Ctries. 2016 Sep 30;10(9):1035-1041
pubmed: 27694739
Trop Parasitol. 2013 Jan;3(1):35-9
pubmed: 23961439
PLoS One. 2013 Aug 26;8(8):e72634
pubmed: 23991132
Gut Pathog. 2014 May 28;6:17
pubmed: 24883113
J Clin Med. 2016 Nov 16;5(11):
pubmed: 27854317
Int J Infect Dis. 2001;5(4):192-8
pubmed: 11953215
Curr HIV/AIDS Rep. 2017 Dec;14(6):211-219
pubmed: 29043609
BMC Res Notes. 2015 Oct 01;8:519
pubmed: 26427622
BMC Infect Dis. 2016 Jan 11;16:9
pubmed: 26754404
Ther Adv Infect Dis. 2013 Oct;1(5):167-78
pubmed: 25165551
J Clin Microbiol. 2016 Mar;54(3):524-8
pubmed: 26677249
J Clin Virol. 2018 Aug;105:72-76
pubmed: 29908520
Microbiome. 2019 Mar 11;7(1):30
pubmed: 30853028
Clin Infect Dis. 2012 Jan 1;54(1):105-10
pubmed: 22075794
Parasitol Int. 2016 Dec;65(6 Pt B):772-779
pubmed: 27181702
Jpn J Infect Dis. 2004 Apr;57(2):41-3
pubmed: 15118206
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
J Infect Dev Ctries. 2013 Oct 15;7(10):763-6
pubmed: 24129632
BMC Infect Dis. 2009 Sep 18;9:155
pubmed: 19765310
Parasit Vectors. 2012 Feb 13;5:36
pubmed: 22330320
Trop Parasitol. 2013 Jan;3(1):17-25
pubmed: 23961437
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2243-2250
pubmed: 28674969
Clin Microbiol Rev. 2008 Oct;21(4):639-65
pubmed: 18854485
Curr Protoc Microbiol. 2016 Nov 18;43:20A.2.1-20A.2.10
pubmed: 27858971
Acta Trop. 2013 Apr;126(1):11-8
pubmed: 23290980
PLoS One. 2014 Mar 24;9(3):e91452
pubmed: 24662743
Ann N Y Acad Sci. 2014 Jan;1308:118-28
pubmed: 24571214
Bioinformatics. 2006 Nov 1;22(21):2688-90
pubmed: 16928733
Mol Biol Evol. 1993 May;10(3):512-26
pubmed: 8336541
AIDS. 2010 Apr 24;24(7):1069-72
pubmed: 20216300
Clin Infect Dis. 2015 Nov 15;61(10):1615-23
pubmed: 26195015
Parasit Vectors. 2008 Oct 21;1(1):40
pubmed: 18937874
J Infect Dev Ctries. 2015 Aug 29;9(8):884-9
pubmed: 26322882
FEMS Microbiol Ecol. 2015 Jul;91(7):
pubmed: 26130823
PLoS One. 2015 Nov 24;10(11):e0143388
pubmed: 26599971
Asian Pac J Trop Med. 2011 Aug;4(8):661-5
pubmed: 21914548
Sci Rep. 2016 May 05;6:25255
pubmed: 27147260
BMC Infect Dis. 2014 Mar 25;14:164
pubmed: 24666632